Information Provided By:
Fly News Breaks for July 17, 2019
INO
Jul 17, 2019 | 10:43 EDT
Piper Jaffray analyst Christopher Raymond lowered his price target on Inovio to $10 from $12 after the company's timelines for VGX-3100 and MEDI0457 shifted. He pushed out his modeled VGX-3100 launch to the second half of 2022 from the second half of 2021 and said the delays "don't exactly bolster our confidence in a timely 2021 VGX-3100 BLA filing," but Raymond added that he thinks the company's restructuring "makes sense," is the right move and may be overdue. He keeps an Overweight rating on Inovio shares.
News For INO From the Last 2 Days
There are no results for your query INO